Hives, also known as urticaria, are raised, itchy welts on your skin that occur due to an allergen. The reaction is ...

Celldex has a strong cash position with a runway of 13-14 quarters, bolstered by a $424 million secondary offering in March 2024. Learn more on CLDX stock here.

The closely watched chronic spontaneous urticaria (CSU, or hives) space chalked more early stage KIT inhibitor data as Third Harmonic Bio Inc. rolled out results from the phase I single and multiple ...

Its medical name is “urticaria.” Hives can be acute (temporary) or chronic (ongoing). The condition is typically characterized by itchy, welts on the skin. Xolair is used to treat chronic ...

Medically reviewed by Brendan Camp, MD Hives and eczema are two of the most common skin disorders. Hives, clinically known as ...

Allakos has announced a 75% workforce reduction and the discontinuation of its chronic spontaneous urticaria (CSU ... CSU – also known as chronic hives—compared the drug to a placebo.

Novartis is just months away from filing for approval of oral BTK inhibitor remibrutinib as a treatment for chronic spontaneous urticaria – also known as chronic hives – after reporting long ...

What if the food you eat and the way you handle stress could make a real difference for your chronic spontaneous urticaria?

Celldex Therapeutics , Inc. (NASDAQ:CLDX), a biopharmaceutical company with a market capitalization of $1.6 billion focused on developing innovative therapies for challenging diseases, has been making ...

but can now point to a win for rilzabrutinib in chronic spontaneous urticaria (CSU). In a phase 2 trial, rilzabrutinib has been shown to rapidly reduce itch severity and significantly improve ...